Send mail to Author

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes : rationale and design of the ODYSSEY Outcomes trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
 ______     _____               _____    _    _    __   __  
|      \\  |  ___||   ____     |  ___|| | || | ||  \ \\/ // 
|  --  //  | ||__    |    \\   | ||__   | || | ||   \ ` //  
|  --  \\  | ||__    | [] ||   | ||__   | \\_/ ||    | ||   
|______//  |_____||  |  __//   |_____||  \____//     |_||   
`------`   `-----`   |_|`-`    `-----`    `---`      `-`'   
                     `-`
 


Back to frontdoor view

OPUS4 Logo